Your browser doesn't support javascript.
loading
TOX is a critical regulator of tumour-specific T cell differentiation.
Scott, Andrew C; Dündar, Friederike; Zumbo, Paul; Chandran, Smita S; Klebanoff, Christopher A; Shakiba, Mojdeh; Trivedi, Prerak; Menocal, Laura; Appleby, Heather; Camara, Steven; Zamarin, Dmitriy; Walther, Tyler; Snyder, Alexandra; Femia, Matthew R; Comen, Elizabeth A; Wen, Hannah Y; Hellmann, Matthew D; Anandasabapathy, Niroshana; Liu, Yong; Altorki, Nasser K; Lauer, Peter; Levy, Olivier; Glickman, Michael S; Kaye, Jonathan; Betel, Doron; Philip, Mary; Schietinger, Andrea.
Afiliación
  • Scott AC; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Dündar F; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.
  • Zumbo P; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
  • Chandran SS; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA.
  • Klebanoff CA; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
  • Shakiba M; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA.
  • Trivedi P; Parker Institute for Cancer Immunotherapy, New York, NY, USA.
  • Menocal L; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Appleby H; Parker Institute for Cancer Immunotherapy, New York, NY, USA.
  • Camara S; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Zamarin D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Walther T; Weill Cornell Medical College, New York, NY, USA.
  • Snyder A; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Femia MR; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
  • Comen EA; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Wen HY; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hellmann MD; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.
  • Anandasabapathy N; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Liu Y; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Altorki NK; Parker Institute for Cancer Immunotherapy, New York, NY, USA.
  • Lauer P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Levy O; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Glickman MS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Kaye J; Parker Institute for Cancer Immunotherapy, New York, NY, USA.
  • Betel D; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Philip M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Schietinger A; Weill Cornell Medical College, New York, NY, USA.
Nature ; 571(7764): 270-274, 2019 07.
Article en En | MEDLINE | ID: mdl-31207604
ABSTRACT
Tumour-specific CD8 T cell dysfunction is a differentiation state that is distinct from the functional effector or memory T cell states1-6. Here we identify the nuclear factor TOX as a crucial regulator of the differentiation of tumour-specific T (TST) cells. We show that TOX is highly expressed in dysfunctional TST cells from tumours and in exhausted T cells during chronic viral infection. Expression of TOX is driven by chronic T cell receptor stimulation and NFAT activation. Ectopic expression of TOX in effector T cells in vitro induced a transcriptional program associated with T cell exhaustion. Conversely, deletion of Tox in TST cells in tumours abrogated the exhaustion program Tox-deleted TST cells did not upregulate genes for inhibitory receptors (such as Pdcd1, Entpd1, Havcr2, Cd244 and Tigit), the chromatin of which remained largely inaccessible, and retained high expression of transcription factors such as TCF-1. Despite their normal, 'non-exhausted' immunophenotype, Tox-deleted TST cells remained dysfunctional, which suggests that the regulation of expression of inhibitory receptors is uncoupled from the loss of effector function. Notably, although Tox-deleted CD8 T cells differentiated normally to effector and memory states in response to acute infection, Tox-deleted TST cells failed to persist in tumours. We hypothesize that the TOX-induced exhaustion program serves to prevent the overstimulation of T cells and activation-induced cell death in settings of chronic antigen stimulation such as cancer.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas del Grupo de Alta Movilidad / Diferenciación Celular / Proteínas de Homeodominio / Linfocitos T CD8-positivos / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nature Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas del Grupo de Alta Movilidad / Diferenciación Celular / Proteínas de Homeodominio / Linfocitos T CD8-positivos / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nature Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos